Skip to main content
SpringerLink
Log in

Pharmacologic Agents to Reverse Hypercalcemic and Hypocalcemic States

  • Chapter
Homeostasis, Nephrotoxicity, and Renal Anomalies in the Newborn

Part of the book series: Developments in Nephrology ((DINE,volume 11))

  • 81 Accesses

Abstract

Calcium concentration in the extracellular fluids is precisely maintained within very narrow limits. Substantial deviations from the norm usually result in symptoms, such as tetany from hypocalcemia or anorexia, nausea, polydipsia, polyuria, constipation, depression, fatigue, muscle weakness and failure to thrive from hypercalcemia.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Corvisart, L.: These de Paris: De la contracture des extremites on tetamie chez l’adulte, 1852.

    Google Scholar 

  2. Cheadle, W. B.: Pathology and treatment of laryngismus tetany and convulsions, illustrated by cases of these disorders in childhood, and also by a case of the tetany of adult life. Lancet 1:919, 1887.

    Article  Google Scholar 

  3. Mundy, G. R. and Martin T. J.: The hypercalcemia of malignancy: pathogenesis and management. Metabolism 31:1247, 1982.

    Article  PubMed  CAS  Google Scholar 

  4. Mannix, H.: Primary hyperparathyroidism in children. Am. J. Surg. 129:528, 1975.

    Article  PubMed  Google Scholar 

  5. Bjernulf, A., Hall, K., Sjogren I. et al: Primary hyperparathyroidism in children. Acta. Ped. Scand. 59:249, 1970.

    Article  CAS  Google Scholar 

  6. Landing, B. H. and Kamoshita, S.: Congenital hyperparathyroidism secondary to maternal hypoparathyroidism. J. Pediatr. 77:842, 1970.

    Article  PubMed  CAS  Google Scholar 

  7. Ibbotson, K. J., D’Souza, S. M., Kanis, J. A. et al: Physiological and pharmacological regulation of bone resorption. Metab. Bone Dis. Rel. Res 2:177, 1980.

    Article  CAS  Google Scholar 

  8. Stewart, A. F., Vignery, A., Silverglate, A., et al.: Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J. Clin. Endocr. Metab. 55:219, 1982.

    Article  PubMed  CAS  Google Scholar 

  9. Maynard, F. M. and Imai, K.: Immobilization hypercalcemia in spinal cord injury. Arch. Phys. Med. Rehabil. 58:16, 1977.

    PubMed  CAS  Google Scholar 

  10. Hung, W., August, G. P., and Glasgow, A. M.: Parathyroids, calcium, and vitamin D. In Pediatric Endocrinology. New York: Medical Examination Publishing Company, 1978, p. 193.

    Google Scholar 

  11. Smith, D. W. and Jones, K. L.: Williams Syndrome. In Recognizable Patterns of Human Malformation. Philadelphia, W. B. Saunders, 1982, p. 100.

    Google Scholar 

  12. David, D. S., Sakai, S., Brennan, L. et al.: Hypercalcemia after renal transplantation: Long-term follow-up data. New Engl. J. Med. 289:398, 1973.

    CAS  Google Scholar 

  13. Conceicao, S. C., Wilkinson, R., Feest, T. G. et al.: Hypercalcemia following renal transplantation: causes and consequences. Clin. Nephrol. 16:235, 1981.

    PubMed  CAS  Google Scholar 

  14. Elliott, G. T. and McKenzie, M. W.: Treatment of hypercalcemia. Drug Intell. Clin. Pharm. 17:12, 1983.

    PubMed  CAS  Google Scholar 

  15. Ragavan, V. V., Smith, J. E. and Bilezikian, J. P.: Vitamin A toxicity and hypercalcemia. Am. J. Med. Sci. 283:161, 1982.

    Article  PubMed  CAS  Google Scholar 

  16. Levine, R. A.: Risk of hypercalcemia from prophylaxis of Travelers’ Diarrhea. JAMA 249:1151, 1983.

    Article  PubMed  CAS  Google Scholar 

  17. Orwoll, E. S.: The milk-alkali syndrome: current concepts. Ann. Int. Med. 97: 242, 1982.

    PubMed  CAS  Google Scholar 

  18. Boyce, B. F., Fell, G. S., Elder, H. Y. et al.: Hypercalcemic osteomalacia due to aluminum toxicity. Lancet 2:1009, 1982.

    Article  PubMed  CAS  Google Scholar 

  19. Tsang, R. C, Noguchi, A. and Steichen, J. J.: Pediatric parathyroid disorders. Ped. Clin. N. Am. 26:223, 1979.

    CAS  Google Scholar 

  20. Tsang, R. C, Chen, I., Friedman, M. A. et al.: Neonatal parathyroid function: Role of gestational age and postnatal age. J. Pediatr. 83:728, 1973.

    Article  PubMed  CAS  Google Scholar 

  21. Rosenbloom, A. L.: Transient congenital idiopathic hypoparathyroidism. South. Med. J. 66:666, 1973.

    Article  Google Scholar 

  22. Hahn, T. J., Halstead, L. R. and Haddad, J. G.: Serum 25-hydroxyvitamin D concentrations in patients receiving chronic corticosteroid treatment. J. Lab. Clin. Med. 90:399, 1977.

    PubMed  CAS  Google Scholar 

  23. Boyle, I. T. and Fogelman, I.: Glucocorticoids and estrogens in management of hypercalcemia. Metab. Bone Dis. Rel. Res. 2:203, 1980.

    Article  Google Scholar 

  24. Adinoff, A. D. and Hollister, J. R.: Steroid-induced fractures and bone loss in patients with asthma. N. Engl. J. Med. 309:265, 1983.

    Article  PubMed  CAS  Google Scholar 

  25. Chan, J. C. M., Young, R. B., Mon, U. et al.: Hypercalcemia in children with disorders of calcium and phosphate during long-term treatment with 1,25-dihydroxyvitamin D3. Pediatr. 72:225, 1983.

    CAS  Google Scholar 

  26. Long, R. G., Wills, M.R. and Skinner, R. K.: Serum 25-hydroxyvitamin-D in untreated parenchymal and cholestatic liver disease. Lancet 2:650, 1976.

    Article  PubMed  CAS  Google Scholar 

  27. Hunter, J., Maxwell, J. D., Stewart, D. A. et al.: Altered calcium metabolism in epileptic children on anticonvulsants. Br. Med. J. 4:202, 1971.

    Article  PubMed  CAS  Google Scholar 

  28. Tolman, K. G., Jubiz, W., Sanella, J. J. et al.: Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children. Pediatr. 56:45, 1975

    CAS  Google Scholar 

  29. Hahn, T. J. and Avioli, L. V.: Anticonvulsant osteomalacia. Arch. Int. Med. 135: 997, 1975.

    Google Scholar 

  30. Jubiz, W., Haussen, M. R., McCain, T. A. et al.: Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs. J. Clin. Endocr. Metab. 44:617, 1977.

    Article  PubMed  CAS  Google Scholar 

  31. Peterson, P., Gray, P. and Tolman, K. G.: Calcium balance in a drug induced osteomalacia: response to vitamin D. Clin. Pharm. Ther. 19:63, 1976.

    CAS  Google Scholar 

  32. Berger, R. E., Gomez, L. S. and Mallette, L. E.: Acute hypocalcemic effects of clinical contrast media injections. AJR 138:283, 1982.

    PubMed  CAS  Google Scholar 

  33. Mallette, L. E. and Gomez, L. S.: Systemic hypocalcemia after clinical injections of radiographic contrast media: amelioration by omission of calcium chelating agents. Radiol. 147:677, 1983.

    CAS  Google Scholar 

  34. Pierce, W. M., Lineberry, M. D. and Waite, L. C: Effect of sulfonamides on the hypercalcemic response to vitamin D. Horm. Metab. Res. 14:670, 1982.

    Article  PubMed  CAS  Google Scholar 

  35. Sleeboom, H. P. and Bijvoet, O. L. M.: Hypercalcemia due to malignancy: role of the kidney and treatment. Contr. Nephrol. 33:178, 1982.

    CAS  Google Scholar 

  36. Stewart, A. F.: Therapy of malignancy associated hypercalcemia. Am. J. Med. 74:475, 1983.

    Article  PubMed  CAS  Google Scholar 

  37. Hosking, D. J.: Treatment of severe hypercalcemia with calcitonin. Metab. Bone Dis. and Rel. Res. 2:207, 1980.

    Article  Google Scholar 

  38. Avioli, L. R.: Calcitonin therapy for bone disease and hypercalcemia. Arch. Int. Med 142:2076, 1982.

    Article  CAS  Google Scholar 

  39. Mundy, G. R., Wilkinson, R. and Health, D. A.: Comparative study of available medical therapy for hypercalcemia of malignancy. Am. J. Med. 74:421, 1983.

    Article  PubMed  CAS  Google Scholar 

  40. Binstock, M. L. and Mundy, G. R.: Effect of calcitonin and glucocorticoids in combination on the hypercalcemia of malignancy. Ann. Int. Med. 93:269, 1989.

    Google Scholar 

  41. Wisneski, L. A., Croom, W. P., Silva, O. L. et al.: Salmon calcitonin in hypercalcemia. Clin. Pharm. Ther. 24:219, 1978.

    CAS  Google Scholar 

  42. Coombes, R. C, Dady, P., Parsons, C. et al.: Mithramycin therapy: an adjunct to conventional treatment of hypercalcemia and bone metastases in breast cancer. Metab. Bone Dis. and Rel. Res. 2:199, 1980.

    Article  Google Scholar 

  43. Strumpf, M., Kowalski, M. A. and Mundy, G. R.: Effects of glucocorticoids on osteoclast activating factor. J. Lab. Clin. Med. 92:272, 1978.

    Google Scholar 

  44. Heath, D. A.: The use of inorganic phosphate in the management of hypercalcemia. Metab. Bone Dis. and Rel. Res. 2:213, 1980.

    Article  Google Scholar 

  45. Martin, T. J. and Partridge, N. C: Prostaglandins, cancer and bone: pharmacological considerations. Metab. Bone Dis. and Rel. Res. 2:167, 1980.

    Article  CAS  Google Scholar 

  46. Baker, J. R. and Wray, H. L.: Early management of hypercalcemic crisis: case report and literature review. Milit. Med. 147:756, 1982.

    CAS  Google Scholar 

  47. Wills, M. R., Bruns, D. E. and Savory, J.: Disorders of calcium homeostasis in the fetus and neonate. Ann. Clin. Lab. Sci 12:79, 1982.

    PubMed  CAS  Google Scholar 

  48. Parfitt, A. M.: Surgical, idiopathic and other varieties of parathyroid hormone deficient hypoparathyroidism. In DeGroot LJ, LaHill GF Jr, Odell WD, Martini L, Potts JT Jr, Nelson DH, Steinberger E, Winegred AI (eds): Endocrinology. New York: Grune & Stratton, Inc., 1979.

    Google Scholar 

  49. Beale, M. G., Chan, J. C. M., Oldham, S. B. et al: Vitamin D: The discovery of its metabolites and their therapeutic applications. Pediatr. 57:729, 1976.

    CAS  Google Scholar 

  50. Mazzuoli, G. F., Coen, C. and Antonozzi, I.: Study on calcium metabolism, thyro-calcitonin assay and effect of thyroidectomy in pseudohypoparathyroidism. Int. J. Med. Sci. 3:627, 1967.

    CAS  Google Scholar 

  51. Drezner, M. K., Neelon, F. A., Haussier, M. et al: 1,25-dihydroxycholecalciferol deficiency: The probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism. J. Clin. Endocrinol. Metab. 42:621, 1976.

    Article  PubMed  CAS  Google Scholar 

  52. Kooh, W. W., Fraser, D., DeLuca, H. F. et al: Treatment of hypoparathyroidism and pseudohypoparathyroidism with metabolites of vitamin D. Evidence for impaired conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D. N. Engl. J. Med. 293:840, 1973.

    Article  Google Scholar 

  53. Alon, U., Wellons, M. D. and Chan, J. C. M.: Reversal of vitamin-D-induced hypercalciuria by chlorothiazide. Pediatr. Res. 17:117, 1983.

    Article  PubMed  CAS  Google Scholar 

  54. Suh, S. M., Tashjian, A. H. and Mutuso, N.: Pathogenesis of hypocalcemia in primary hypomagnesemia: Normal end-organ responsiveness to parathyroid hormone, impaired parathyroid gland function. J. Clin. Invest. 52:153, 1973.

    Article  PubMed  CAS  Google Scholar 

  55. Harrison, H. E. and Harrison, H. C: In Disorders of Calcium and Phosphate Metabolism in Childhood and Adolescence. Philadelphia: W. B. Saunders Co., 1979, p. 314.

    Google Scholar 

  56. Alon, U. and Chan, J. C. M.: Calcium and Vitamin-D homeostasis in the nephrotic syndrome. Nephron 36:1, 1984.

    Article  PubMed  CAS  Google Scholar 

  57. Alon, U. and Chan, J. C. M.: Calcium and vitamin-D metabolism in nephrotic syndrome. Int. J. Pediatr. Nephrol. 4:115, 1983.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Robert J. Geller M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James C. M. Chan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Pediatric Nephrology, School of Medicine, University of Miami, Miami, Florida, USA

    José Strauss MD

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Martinus Nijhoff Publishing, Boston

About this chapter

Cite this chapter

Geller, R.J., Chan, J.C.M. (1986). Pharmacologic Agents to Reverse Hypercalcemic and Hypocalcemic States. In: Strauss, J. (eds) Homeostasis, Nephrotoxicity, and Renal Anomalies in the Newborn. Developments in Nephrology, vol 11. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2637-3_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-2637-3_15

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4612-9647-8

  • Online ISBN: 978-1-4613-2637-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation